Clinical experience with an injectable hormonal contraceptive depot

Authors

  • Alfredo Larrañaga Leguía Revista Peruana de Obstetricia y Ginecología, Lima, Perú
  • Esteban Kesseru Revista Peruana de Obstetricia y Ginecología, Lima, Perú

DOI:

https://doi.org/10.31403/rpgo.v13i878

Abstract

207 highly fertile Peruvian females were studied with a long-acting hormonal contraceptive; this compound was a synthetic gestagen: Norethindrone enanthate; with a dose of 200 mg. every three months there were no pregnancies in a group of 134 patients. In 53 patients receiving the some dose every 4 months occurred 3 pregnancies, demonstrating the reversibility of the contraceptive mechanism. Side effects were observed in the first 3 months with the usual incidence for oral contraceptives, but they diminished to 2.9 % after this period of time. The authors remark the persistence of lactation and disappearance of dysmenorrhea that occurred in most of the patients.

Downloads

Download data is not yet available.

Published

2015-06-12

How to Cite

Larrañaga Leguía, A., & Kesseru, E. (2015). Clinical experience with an injectable hormonal contraceptive depot. The Peruvian Journal of Gynecology and Obstetrics, 13(1 y 2), 49–58. https://doi.org/10.31403/rpgo.v13i878

Issue

Section

Artículos Originales

Most read articles by the same author(s)

> >>